Skip to main content
Clinical Trials/NCT04872517
NCT04872517RecruitingNot Applicable

Detecting Changes Before and After Chemotherapy or Radiotherapy in Patients With Head and Neck Cancer by Meridian Electroacupuncture Analysis Device (MEAD)

Liao Jian An2 sites in 1 country34 target enrollmentStarted: April 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
34
Locations
2
Primary Endpoint
meridian energy

Study Overview

Brief Summary

This trial is conducted by using MEAD to detect the meridian changes in patients with head and neck cancer after conventional treatment of chemotherapy or radiotherapy.

Detailed Description

The purpose of this research is observe the change of meridian energy in patients have be diagnosed with head and neck cancer. The instrument we use is a non-invasive device called meridian energy analysis device(MEAD). The theory of MEAD is use conductive rod to measure the skin resistance from the specific point in human body, and to calculate the meridian's energy change. In Traditional Chinese Medicine theory, physician doctor believe that the median in human body would be affected by disease or uncomfortable condition. So, this time, we who a group of physician of Traditional Chinese medicine department conduct this research to assess the energy change in patients with head and neck cancer. The trail cooperate with radiation oncology department and hematology oncology department. Subject enrollment from radiation oncology department and hematology Oncology department. All of subjects have be diagnosed with head and neck cancer, and will to receive conventional treatment, no matter chemotherapy or/and radiotherapy.

The major assessment of our research is meridian energy by MEAD before treatment, and six consecutive cycles. In addition to this, pain degree, oral mucositis condition, impact on life quality, and blood test, diagnosis imaging data will be collected.

According to G*Power( 3.1.9.4 edition), we expected to recruit 34 subjects. All of Statistical Analysis will use SPSS, pair-t test is used to analyze continuous variable, categorical variable will be analyzed by Chi-Square Test. Multivariate regression analysis will be apply to discuss the major factor of the meridian changes.

MEAD is a kind of non-invasive device, hasn't had adverse effect until now. We will start emergency handling If accidents happened within measurement.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
20 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • patients with head and neck cancer, included nasopharyngeal carcinoma, laryngeal cancer, oropharyngeal cancer, ear and oral cancer, hypopharyngeal cancer, salivary-gland carcinoma. Aged between 20 years old to 75years old, no gender difference.
  • patients with head and neck cancer has not received surgery yet, and will plan to accept chemotherapy and/or radiotherapy.
  • recurrent head and neck cancer, and expect to received chemotherapy and/or radiotherapy.
  • patient with vital sings stableness, conscious clear, and have ability to recognize the contain of trail and sign consent.
  • not accept other adjuvant therapy.
  • no brain metastasis or psychosis, and will to join whole course as well as accept assessments.

Exclusion Criteria

  • Aged less than 20 years old and over 75 years old。
  • Patients be diagnosed with head and neck cancer, and accepted surgery, or already finished chemotherapy and/or radiotherapy.
  • patient with brain metastasis, conscious unclear, and have not able to recognize the contain of trail and sign consent.
  • Accept other adjuvant therapy and chemotherapy and/or radiotherapy simultaneously.
  • Combined with serious organs failure。
  • Have contraindication in chemotherapy or radiotherapy.

Outcomes

Primary Outcomes

meridian energy

Time Frame: An average of 6 weeks

energy change in meridian

Secondary Outcomes

  • pain degree(An average of 6 weeks)
  • Oral mucositis grading(An average of 6 weeks)
  • the number of participants with blood test data abnormal(An average of 6 weeks)
  • adverse impact on quality of life(An average of 6 weeks)
  • imaging diagnosis(An average of 6 weeks)

Investigators

Sponsor
Liao Jian An
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Liao Jian An

Attending physician of Traditional Chinese Medicine department

Chang Gung Memorial Hospital

Study Sites (2)

Loading locations...

Similar Trials